Variable selection in finite mixture of regression models using the skew-normal distribution. [PDF]
Yin J, Wu L, Dai L.
europepmc +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
LIII. On a peculiarity of the normal component of the attraction due to certain surface distributions [PDF]
Ganesh Prasad
openalex +1 more source
Optimizing brushless direct current motor design: An application of the multi-objective generalized normal distribution optimization. [PDF]
Pandya SB+5 more
europepmc +1 more source
Inference on a progressive type I interval-censored truncated normal distribution. [PDF]
Lodhi C, Tripathi YM.
europepmc +1 more source
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
On the Characteristic Functions of the Distributions of Estimates of Various Deviations in Samples from a Normal Population [PDF]
Mark Kac
openalex +1 more source
Microscopic parasite malaria classification using best feature selection based on generalized normal distribution optimization. [PDF]
Amin J+5 more
europepmc +1 more source
Log-epsilon-skew normal: A generalization of the log-normal distribution. [PDF]
Hutson AD, Mashtare TL, Mudholkar GS.
europepmc +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source